Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Article

Abstract: Background: There is little evidence on the use of secondary prevention medicines for cardiovascular

Palabras claves:

Autores:

Alhabib K.F., Avezum A.J., Bai X., Chifamba J., Chow C.K., Corsi D.J., Dagenais G.R., Dans A.M., DIaz R., Erbakan A.N., Iqbal R., Kelishadi R., Khatib R., Lanas F., Lear S.A., Li W., Liu J., Mckee M., Mohan V., Monsef N., Mony P.K., Murphy A., Noorhassim I., O'Donnell O., Palafox B., PATRICIO LOPEZ -JARAMILLO, Perel P., Puoane T., Rangarajan S., Rosengren A., Schutte A.E., Sintaha M., Stuckler D., Teo K.K., Wielgosz A., Yeates K.E., Yin L., Yusoff K., Yusuf S., Zatońska K.

Fuentes:

google

scopus